Alembic Pharmaceuticals Ltd (BOM:533573)
â‚ą 1039 -42.45 (-3.93%) Market Cap: 204.23 Bil Enterprise Value: 213.40 Bil PE Ratio: 31.60 PB Ratio: 4.18 GF Score: 91/100

Q1 2020 Alembic Pharmaceuticals Ltd Earnings Call Transcript

Jul 29, 2019 / 11:00AM GMT
Release Date Price: â‚ą530.1 (-0.89%)
Operator

Good day, ladies and gentlemen, and welcome to the Q1 FY '20 Earnings Conference Call of Alembic Pharmaceuticals Limited.

We have with us today from the management Mr. Pranav Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head of Finance; Mr. Jesal Shah, Head Strategy; and Mr. Ajay Kumar Desai, Senior VP Finance. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. R.K. Baheti. Thank you, and over to you, sir.

Raj Kumar Shreeram Baheti
Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director

Thank you, and thank you all participants for joining the Q1 conference call. I will straightaway go to the numbers.

During the quarter, our total revenue grew by 10% to INR 949 crores. EBITDA at INR 233 crore is 25% of sales.

Pre R&D EBITDA is 38% of sales. Profit before exceptional items and tax went up by 58% to INR 192 crores while post exceptional item and tax, it went up by 37% to INR 124 croresâ¦

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot